Lyell Immunopharma, Inc. (LYEL)
NASDAQ·Healthcare·Biotechnology
$10.35
-7.31%
Mkt Cap $279.31M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (8 analysts)
$47.00
Range $45.00 – $49.00
Implied Upside
+354.3%
Consensus $47.00 vs current $10.35
NASDAQ·Healthcare·Biotechnology
$10.35
-7.31%
Mkt Cap $279.31M
Buy
2
Hold
0
Sell
0
Price Target (8 analysts)
$47.00
Range $45.00 – $49.00
+354.3%
Consensus $47.00 vs current $10.35